United States · 
Who invested in Tessera Therapeutics?
Tessera Therapeutics's investors include SoftBank, SoftBank Vision Fund, Cormorant Asset Management and Artis Ventures (AV).
2026
$150MVenture?Venture
United States · Venture startup
Who invested in Tessera Therapeutics
Funding summaryUpdated 26 Oct 2026
$150Mraised across 2 rounds since 2025, from 2 sources
- Latest round
- VentureMar 2026
- Biggest round
- $150MVenture · Dec 2025
- Investors
- 4
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $150M Dec 2025
- Biggest round
- $150M Venture · Dec 2025
- Between rounds
- 3 months from the last two
The rounds
- Mar 2026VentureAmount undisclosed4 returning
Source recorded
- Dec 2025Venture$150M4 new
Source recorded
Founders and team
From Tessera Therapeutics's own website: 15 on the team.
- Joseph RomanelliPresident and Chief Executive Officer, Board Director
- Cecilia Cotta-RamusinoSenior Vice President, Head of Platform
- Navreet DhindsaSenior Vice President, Clinical Operations
- Becky LillieChief Human Resources Officer
- David DavidsonChief Medical and Development Officer
- Hari PujarChief Operating Officer
- Kathy BergsteinssonChief Financial Officer
- Michael HolmesChief Scientific Officer
- Cynthia PattonGeneral Counsel and Secretary
- Derica RiceBoard Director
- Elliott SigalBoard Director
- Geoffrey von MaltzahnBoard Chair
- Jacob RubensBoard Chair
- Mary RozenmanBoard Director
- Paul BiondiBoard Director
AdvisersBritt AdamsonDavid A. WilliamsDavid SchafferErik SontheimerGeorge ChurchJef BoekeJohn MoranJonathan WeissmanLuigi NaldiniMelissa Moore
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
SoftBank Vision FundVC firm2rounds
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 4 firms list Tessera Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Tessera Therapeutics
How much has Tessera Therapeutics raised?
Tessera Therapeutics has raised $150M across 2 rounds since 2025. One round did not disclose an amount, so the total is a floor.
When did Tessera Therapeutics last raise?
Tessera Therapeutics's most recent round was a Venture in Mar 2026.
What was Tessera Therapeutics's biggest round?
Tessera Therapeutics's largest round on record is $150M (Venture), in Dec 2025.
Who backed Tessera Therapeutics first?
Tessera Therapeutics's first round on record, in Dec 2025, was backed by SoftBank, SoftBank Vision Fund and Cormorant Asset Management and 1 others.
What stage is Tessera Therapeutics at?
Tessera Therapeutics's latest named round is a Venture, in Mar 2026.
Where is Tessera Therapeutics based?
Tessera Therapeutics is based in the United States.
Companies like Tessera Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.